(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 9.56%1.43B | 24.26%1.39B | 24.84%950M | -6.49%4.5B | 16.70%1.31B | 0.54%1.31B | -10.64%1.12B | -32.95%761M | 9.64%4.81B | 25.67%1.13B |
Net income from continuing operations | 87.59%257M | 12.76%221M | -37.50%140M | -49.53%867M | 16.98%310M | -75.14%137M | -60.64%196M | -44.55%224M | 1.18%1.72B | -60.03%265M |
Operating gains losses | 11.76%19M | 10.00%22M | 131.58%88M | 215.29%98M | -30.00%42M | 113.71%17M | 138.46%20M | 22.58%38M | 70.38%-85M | 115.79%60M |
Depreciation and amortization | -3.20%968M | -1.19%994M | 4.01%1.06B | 17.87%4.07B | 12.06%1.04B | 17.65%1B | 21.06%1.01B | 21.38%1.02B | 7.34%3.45B | 11.93%929M |
Remuneration paid in stock | 62.96%44M | 30.00%39M | -37.21%27M | -4.10%117M | -29.17%17M | -10.00%27M | -28.57%30M | 65.38%43M | -12.23%122M | 50.00%24M |
Deferred tax | -19.39%-117M | -94.44%-70M | -5.38%-98M | -551.61%-140M | 680.00%87M | -288.46%-98M | -620.00%-36M | -9,200.00%-93M | -34.04%31M | -124.19%-15M |
Other non cashItems | -1,600.00%-45M | -48.00%-37M | -575.00%-57M | 20.51%-186M | -57.14%-242M | 105.88%3M | -152.08%-25M | 115.58%12M | 31.78%-234M | 6.10%-154M |
Change In working capital | 38.46%306M | 395.95%219M | 56.08%-213M | -68.91%-326M | 247.06%59M | 2,862.50%221M | 33.93%-74M | -438.89%-485M | -135.37%-193M | 112.98%17M |
-Change in receivables | 73.21%-30M | 540.00%64M | 8.52%191M | 37.95%-188M | -43.17%-262M | 40.11%-112M | 105.41%10M | -30.16%176M | -1.68%-303M | -48.78%-183M |
-Change in inventory | 26.67%38M | 125.00%9M | -17.02%-55M | 159.55%53M | 273.68%66M | 148.39%30M | -94.74%4M | 27.69%-47M | -117.07%-89M | 67.24%-38M |
-Change in prepaid assets | 93.18%85M | -13.21%-60M | 0.74%-135M | -7.14%-60M | -40.51%94M | 204.76%44M | -76.67%-53M | 4.23%-136M | -40.00%-56M | 203.85%158M |
-Change in payables and accrued expense | 0.93%109M | 966.67%192M | 58.56%-225M | -254.91%-268M | 24.17%149M | -48.57%108M | 1,000.00%18M | -250.32%-543M | -40.14%173M | 126.42%120M |
-Change in other current liabilities | 66.67%-3M | -500.00%-4M | ---- | ---- | ---- | ---9M | --1M | ---- | ---- | ---- |
-Change in other working capital | -33.13%107M | 133.33%18M | -83.08%11M | 67.07%137M | 115.00%6M | 119.18%160M | -286.21%-54M | 225.00%65M | 925.00%82M | -1,433.33%-40M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 9.56%1.43B | 24.26%1.39B | 24.84%950M | -6.49%4.5B | 16.70%1.31B | 0.54%1.31B | -10.64%1.12B | -32.95%761M | 9.64%4.81B | 25.67%1.13B |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 1.14%-782M | -38.22%-1.26B | 57.48%-992M | 12.20%-4.75B | 16.16%-716M | 58.74%-791M | 36.86%-908M | -94.58%-2.33B | 1.06%-5.41B | 57.06%-854M |
Net PPE purchase and sale | 8.86%-679M | 14.29%-666M | 16.80%-812M | 12.75%-3.18B | 12.98%-684M | 10.46%-745M | 23.52%-777M | 3.65%-976M | -17.76%-3.65B | 8.60%-786M |
Net intangibles purchas and sale | --0 | -9,820.00%-496M | ---124M | ---29M | --0 | ---24M | ---5M | --0 | --0 | --0 |
Net business purchase and sale | -727.27%-91M | -1,114.29%-71M | 94.06%-75M | 16.59%-1.28B | 75.00%-11M | 98.92%-11M | 102.02%7M | -934.43%-1.26B | -3,927.50%-1.53B | -108.80%-44M |
Net investment purchase and sale | -200.00%-7M | 8.70%-21M | 121.74%20M | 38.32%-132M | -200.00%-24M | 110.61%7M | 69.33%-23M | -41.54%-92M | -44.59%-214M | 85.45%-8M |
Net other investing changes | 72.22%-5M | 99.09%-1M | 66.67%-1M | -700.00%-128M | --3M | ---18M | -10,900.00%-110M | -400.00%-3M | 61.90%-16M | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 1.14%-782M | -38.22%-1.26B | 57.48%-992M | 12.20%-4.75B | 16.16%-716M | 58.74%-791M | 36.86%-908M | -94.58%-2.33B | 1.06%-5.41B | 57.06%-854M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -2,056.41%-763M | -213.50%-1.37B | -9.02%1.34B | -83.61%139M | -27.10%-938M | -97.67%39M | -114.22%-437M | 1,182.61%1.48B | -11.02%848M | -1,437.50%-738M |
Net issuance payments of debt | -189.82%-353M | -1,439.34%-939M | -4.51%1.72B | -30.57%1.53B | -56.40%-599M | -80.30%393M | -135.67%-61M | 326.07%1.8B | 3,205.63%2.21B | -271.75%-383M |
Cash dividends paid | -13.61%-384M | -34.69%-431M | -12.89%-359M | -10.69%-1.32B | -10.06%-339M | -13.80%-338M | -10.34%-320M | -8.53%-318M | -13.68%-1.19B | -13.24%-308M |
Net other financing activities | -62.50%-26M | ---- | -220.00%-16M | 54.44%-77M | --0 | 30.43%-16M | 34.12%-56M | 64.29%-5M | -121.98%-169M | -4,800.00%-47M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -2,056.41%-763M | -213.50%-1.37B | -9.02%1.34B | -83.61%139M | -27.10%-938M | -97.67%39M | -114.22%-437M | 1,182.61%1.48B | -11.02%848M | -1,437.50%-738M |
Net cash flow | ||||||||||
Beginning cash position | 42.84%927M | 146.75%2.16B | -11.29%864M | 34.72%974M | -16.39%1.2B | 69.90%649M | 13.31%877M | 34.72%974M | -14.74%723M | -22.75%1.44B |
Current changes in cash | -120.36%-113M | -442.54%-1.24B | 1,440.21%1.3B | -143.82%-110M | 27.04%-340M | -47.54%555M | 41.84%-228M | -290.20%-97M | 300.80%251M | 59.16%-466M |
End cash Position | -32.39%814M | 42.84%927M | 146.75%2.16B | -11.29%864M | -11.29%864M | -16.39%1.2B | 69.90%649M | 13.31%877M | 34.72%974M | 34.72%974M |
Free cash from | 39.96%753M | -32.54%226M | 106.51%14M | 10.65%1.29B | 85.29%630M | 14.96%538M | 43.16%335M | -276.23%-215M | 225.43%1.16B | 122.34%340M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data